Lentivirus-mediated knockdown of eukaryotic translation initiation factor 3 subunit D inhibits proliferation of HCT116 colon cancer cells

Bioscience Reports

Volumn 34, Issue 6, 2014, Pages 823-830

  Yu, Xiaojun ^a   Zheng, Bo'an ^a   Chai, Rui ^a  

^a ZHEJIANG PROVINCIAL PEOPLE'S HOSPITAL   (China)

Author keywords

Apoptosis; Colon cancer; EIF3D; Growth; RNA interference

Indexed keywords

CELL PROTEIN; EUKARYOTIC TRANSLATION INITIATION FACTOR 3 SUBUNIT D; GLYCOGEN SYNTHASE KINASE 3BETA; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE KINASE; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE KINASE ALPHA; INITIATION FACTOR 3; LENTIVIRUS VECTOR; NICOTINAMIDE ADENINE DINUCLEOTIDE ADENOSINE DIPHOSPHATE RIBOSYLTRANSFERASE; PROLINE RICH AKT SUBSTRATE OF 40 KDA PROTEIN; PROTEIN BAD; SHORT HAIRPIN RNA; STRESS ACTIVATED PROTEIN KINASE; UNCLASSIFIED DRUG; BAD PROTEIN, HUMAN; GLYCOGEN SYNTHASE KINASE 3; GLYCOGEN SYNTHASE KINASE 3 BETA; PRKAA1 PROTEIN, HUMAN;

APOPTOSIS; ARTICLE; BIOACCUMULATION; CANCER GROWTH; CANCER INHIBITION; CELL GROWTH; CELL PROLIFERATION; COLON CANCER; COLON CARCINOGENESIS; COLONY FORMATION; CONTROLLED STUDY; FLOW CYTOMETRY; G2 PHASE CELL CYCLE CHECKPOINT; HCT116 CELL LINE; HUMAN; HUMAN CELL; IN VITRO STUDY; PROTEIN DEPLETION; PROTEIN EXPRESSION; RNA INTERFERENCE; CELL CYCLE G1 PHASE; COLON TUMOR; GENE EXPRESSION REGULATION; GENE VECTOR; GENETICS; HEK293 CELL LINE; LENTIVIRINAE; METABOLISM; PATHOLOGY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; WESTERN BLOTTING;

EUKARYOTA; LENTIVIRUS;

AMP-ACTIVATED PROTEIN KINASES; APOPTOSIS; BCL-ASSOCIATED DEATH PROTEIN; BLOTTING, WESTERN; CELL PROLIFERATION; COLONIC NEOPLASMS; EUKARYOTIC INITIATION FACTOR-3; G1 PHASE; G2 PHASE CELL CYCLE CHECKPOINTS; GENE EXPRESSION REGULATION, NEOPLASTIC; GENETIC VECTORS; GLYCOGEN SYNTHASE KINASE 3; HCT116 CELLS; HEK293 CELLS; HUMANS; JNK MITOGEN-ACTIVATED PROTEIN KINASES; LENTIVIRUS; POLY(ADP-RIBOSE) POLYMERASES; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA INTERFERENCE; SIGNAL TRANSDUCTION;

EID: 84919619702     PISSN: 01448463     EISSN: 15734935     Source Type: Journal    
DOI: 10.1042/BSR20140078     Document Type: Article

References (37)

1. Cunningham, D., Atkin, W., Lenz, H. J., Lynch, H. T., Minsky, B., Nordlinger, B. and Starling, N. (2010) Colorectal cancer. Lancet 375, 1030-1047 CrossRef PubMed
2. Watson, A. J. and Collins, P. D. (2011) Colon cancer: a civilization disorder. Dig. Dis. 29, 222-228 CrossRef PubMed
3. Lee, I. M., Shiroma, E. J., Lobelo, F., Puska, P., Blair, S. N., Katzmarzyk, P. T. and Lancet Physical Activity Series Working, G. (2012) Effect of physical inactivity on major non-communicable diseases worldwide: an analysis of burden of disease and life expectancy. Lancet 380, 219-229 CrossRef PubMed
4. Stein, A., Atanackovic, D. and Bokemeyer, C. (2011) Current standards and new trends in the primary treatment of colorectal cancer. Eur. J. Cancer 47, S312-S314 CrossRef PubMed
5. Lozano, R., Naghavi, M., Foreman, K., Lim, S., Shibuya, K., Aboyans, V., Abraham, J., Adair, T., Aggarwal, R., Ahn, S. Y. et al. (2012) Global and regional mortality from 235 causes of death for 20. age groups in 1990 and 2010: a systematic analysis for the global burden of disease study 2010. Lancet 380, 2095-2128 CrossRef PubMed
6. Gansler, T., Ganz, P. A., Grant, M., Greene, F. L., Johnstone, P., Mahoney, M., Newman, L. A., Oh, W. K., Thomas, Jr, C. R., Thun, M. J. et al. (2010) Sixty years of CA: a cancer journal for clinicians. CA: Cancer J. Clin. 60, 345-350 CrossRef PubMed
7. Merika, E., Saif, M. W., Katz, A., Syrigos, K. and Morse, M. (2010) Review. Colon cancer vaccines: an update. In Vivo 24, 607-628 PubMed
8. Pestova, T. V. and Kolupaeva, V. G. (2002) The roles of individual eukaryotic translation initiation factors in ribosomal scanning and initiation codon selection. Genes Dev. 16, 2906-2922 CrossRef PubMed
9. Algire, M. A., Maag, D. and Lorsch, J. R. (2005) Pi release from eIF2, not GTP hydrolysis, is the step controlled by start-site selection during eukaryotic translation initiation. Mol. Cell 20, 251-262 CrossRef PubMed
10. Pena, V., Liu, S., Bujnicki, J. M., Luhrmann, R. and Wahl, M. C. (2007) Structure of a multipartite protein-protein interaction domain in splicing factor prp8 and its link to retinitis pigmentosa. Mol. Cell 25, 615-624 CrossRef PubMed
11. Enchev, R. I., Schreiber, A., Beuron, F. and Morris, E. P. (2010) Structural insights into the COP9 signalosome and its common architecture with the 26S proteasome lid and eIF3. Structure 18, 518-527 CrossRef PubMed
12. Hinnebusch, A. G. (2006) eIF3: a versatile scaffold for translation initiation complexes. Trends Biochem. Sci. 31, 553-562 CrossRef PubMed
13. Jackson, R. J., Hellen, C. U. and Pestova, T. V. (2010) The mechanism of eukaryotic translation initiation and principles of its regulation. Nat. Rev. Mol. Cell Biol. 11, 113-127 CrossRef PubMed
14. Valasek, L. S. (2012) 'Ribozoomin'-translation initiation from the perspective of the ribosome-bound eukaryotic initiation factors (eIFs). Curr. Protein Pept. Sci. 13, 305-330 CrossRef PubMed
15. Jager, S., Cimermancic, P., Gulbahce, N., Johnson, J. R., McGovern, K. E., Clarke, S. C., Shales, M., Mercenne, G., Pache, L., Li, K. et al. (2011) Global landscape of HIV-human protein complexes. Nature 481, 365-370 PubMed
16. Bandyopadhyay, A., Lakshmanan, V., Matsumoto, T., Chang, E. C. and Maitra, U. (2002) Moe1 and spInt6, the fission yeast homologues of mammalian translation initiation factor 3 subunits p66 (eIF3d) and p48 (eIF3e), respectively, are required for stable association of eIF3 subunits. J. Biol. Chem. 277, 2360-2367 CrossRef PubMed
17. Yin, H., Liang, Y., Yan, Z., Liu, B. and Su, Q. (2013) Mutation spectrum in human colorectal cancers and potential functional relevance. BMC Med. Genet. 14, 32 CrossRef PubMed
18. Sakoda, T., Kasahara, N., Hamamori, Y. and Kedes, L. (1999) A high-titer lentiviral production system mediates efficient transduction of differentiated cells including beating cardiac myocytes. J. Mol. Cell. Cardiol. 31, 2037-2047 CrossRef PubMed
19. Xu, M., Wang, Y., Chen, L., Pan, B., Chen, F., Fang, Y., Yu, Z. and Chen, G. (2014) Down-regulation of ribosomal protein S15A mRNA with a short hairpin RNA inhibits human hepatic cancer cell growth in vitro. Gene 536, 84-89 CrossRef PubMed
20. Spilka, R., Ernst, C., Mehta, A. K. and Haybaeck, J. (2013) Eukaryotic translation initiation factors in cancer development and progression. Cancer Lett. 340, 9-21 CrossRef PubMed
21. Riccardi, C. and Nicoletti, I. (2006) Analysis of apoptosis by propidium iodide staining and flow cytometry. Nat. Protoc. 1, 1458-1461 CrossRef PubMed
22. Carling, D., Mayer, F. V., Sanders, M. J. and Gamblin, S. J. (2011) AMP-activated protein kinase: nature's energy sensor. Nat. Chem. Biol. 7, 512-518 CrossRef PubMed
23. Mihaylova, M. M. and Shaw, R. J. (2011) The AMPK signalling pathway coordinates cell growth, autophagy and metabolism. Nat. Cell Biol. 13, 1016-1023 CrossRef PubMed
24. Hardie, D. G., Ross, F. A. and Hawley, S. A. (2012) AMPK: a nutrient and energy sensor that maintains energy homeostasis. Nat. Rev.: Mol. Cell Biol. 13, 251-262 CrossRef PubMed
25. Konishi, Y., Lehtinen, M., Donovan, N. and Bonni, A. (2002) Cdc2 phosphorylation of BAD links the cell cycle to the cell death machinery. Mol. Cell 9, 1005-1016 CrossRef PubMed
26. Thedieck, K., Polak, P., Kim, M. L., Molle, K. D., Cohen, A., Jeno, P., Arrieumerlou, C. and Hall, M. N. (2007) PRAS40 and PRR5-like protein are new mTOR interactors that regulate apoptosis. PloS ONE 2, e1217 CrossRef PubMed
27. Satomi, Y. (2012) Fucoxanthin induces GADD45A expression and G1 arrest with SAPK/JNK activation in LNCap human prostate cancer cells. Anticancer Res. 32, 807-813 PubMed
28. Chang, L. and Karin, M. (2001) Mammalian MAP kinase signalling cascades. Nature 410, 37-40 CrossRef PubMed
29. Cross, D. A., Alessi, D. R., Cohen, P., Andjelkovich, M. and Hemmings, B. A. (1995) Inhibition of glycogen synthase kinase-3 by insulin mediated by protein kinase B. Nature 378, 785-789 CrossRef PubMed
30. Jacobs, K. M., Bhave, S. R., Ferraro, D. J., Jaboin, J. J., Hallahan, D. E. and Thotala, D. (2012) GSK-3beta: A bifunctional role in cell death pathways. Int. J. Cell Biol. 2012, 930710 CrossRef PubMed
31. Min, H. J., Koh, S. S., Cho, I. R., Srisuttee, R., Park, E. H., Jhun, B. H., Kim, Y. G., Oh, S., Kwak, J. E., Johnston, R. N. and Chung, Y. H. (2009) Inhibition of GSK-3beta enhances reovirus-induced apoptosis in colon cancer cells. Int. J. Oncol. 35, 617-624 PubMed
32. Bressenot, A., Marchal, S., Bezdetnaya, L., Garrier, J., Guillemin, F. and Plenat, F. (2009) Assessment of apoptosis by immunohistochemistry to active caspase-3, active caspase-7, or cleaved PARP in monolayer cells and spheroid and subcutaneous xenografts of human carcinoma. J. Histochem. Cytochem. 57, 289-300 CrossRef PubMed
33. Sudo, H., Tsuji, A. B., Sugyo, A., Kohda, M., Sogawa, C., Yoshida, C., Harada, Y. N., Hino, O. and Saga, T. (2010) Knockdown of COPA, identified by loss-of-function screen, induces apoptosis and suppresses tumor growth in mesothelioma mouse model. Genomics 95, 210-216 CrossRef PubMed
34. Kim, H. K., Choi, I. J., Kim, C. G., Kim, H. S., Oshima, A., Michalowski, A. and Green, J. E. (2011) A gene expression signature of acquired chemoresistance to cisplatin and fluorouracil combination chemotherapy in gastric cancer patients. PloS ONE 6, e16694 CrossRef PubMed
35. Morcos, P. A. (2007) Achieving targeted and quantifiable alteration of mRNA splicing with Morpholino oligos. Biochem. Biophys. Res. Commun. 358, 521-527 CrossRef PubMed
36. Bennett, C. F. and Swayze, E. E. (2010) RNA targeting therapeutics: molecular mechanisms of antisense oligonucleotides as a therapeutic platform. Annu. Rev. Pharmacol. Toxicol. 50, 259-293 CrossRef PubMed
37. Watts, J. K. and Corey, D. R. (2012) Silencing disease genes in the laboratory and the clinic. J. Pathol. 226, 365-379 CrossRef PubMed